{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T19:32:39Z","timestamp":1760297559632},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[1992,2,1]],"date-time":"1992-02-01T00:00:00Z","timestamp":696902400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp Brain Res"],"published-print":{"date-parts":[[1992,2]]},"DOI":"10.1007\/bf02259102","type":"journal-article","created":{"date-parts":[[2005,11,23]],"date-time":"2005-11-23T00:48:13Z","timestamp":1132706893000},"page":"277-282","source":"Crossref","is-referenced-by-count":18,"title":["Comparative analysis of seizures induced by intracerebroventricular administration of NMDA, kainate and quisqualate in mice"],"prefix":"10.1007","volume":"88","author":[{"given":"C.","family":"Mathis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Ungerer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF02259102_CR1","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1152\/jn.1989.61.3.589","volume":"61","author":"M Avoli","year":"1989","unstructured":"Avoli M, Olivier A (1989) Electrophysiological properties and synaptic responses in the deep layers of the human epileptogenic neocortex in vitro. J Neurophysiol 61: 589\u2013606","journal-title":"J Neurophysiol"},{"key":"BF02259102_CR2","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/0306-4522(85)90299-4","volume":"14","author":"Y Ben-Ari","year":"1985","unstructured":"Ben-Ari Y (1985) Limbic seizure and brain damage produced by kainic acid: mechanisms and relevance to human temporal lobe epilepsy. Neuroscience 14: 375\u2013403","journal-title":"Neuroscience"},{"key":"BF02259102_CR3","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1016\/0306-4522(81)90193-7","volume":"6","author":"Y Ben-Ari","year":"1981","unstructured":"Ben-Ari Y, Tremblay E, Riche D, Ghilini G, Naquet R (1981) Electrographic, clinical and pathological alterations following systemic administration of kainic acid, bicuculline or pentetrazole: metabolic mapping using the deoxyglucose method with special reference to the pathology of epilepsy. Neuroscience 6: 1361\u20131391","journal-title":"Neuroscience"},{"key":"BF02259102_CR4","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/0014-4886(86)90174-3","volume":"93","author":"RA Browning","year":"1986","unstructured":"Browning RA, Nelson DK (1986) Modification of electroshock and pentylenetetrazol seizure patterns in rats after precollicular transections. Exp Neurol 93: 546\u2013556","journal-title":"Exp Neurol"},{"key":"BF02259102_CR5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0920-1211(90)90002-D","volume":"6","author":"R Browning","year":"1990","unstructured":"Browning R, Wang C, Lanker ML, Jobe PC (1990) Electroshock-and pentylenetetrazol-induced seizures in genetically epilepsyprone rats (GEPRs): differences in threshold and pattern. Epilepsy Res 6: 1\u201311","journal-title":"Epilepsy Res"},{"key":"BF02259102_CR6","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/0304-3940(85)90456-2","volume":"55","author":"AG Chapman","year":"1985","unstructured":"Chapman AG, Hart GP, Meldrum BS, Turski L, Watkins JC (1985) Anticonvulsant activity of two novel piperazine derivatives with potent kainate antagonist activity. Neurosci Lett 55: 325\u2013330","journal-title":"Neurosci Lett"},{"key":"BF02259102_CR7","first-page":"347","volume-title":"Experimental models of epilepsy- a manual for the laboratory worker","author":"RL Collins","year":"1972","unstructured":"Collins RL (1972) Audiogenic seizures. In: Purpura DP, Penry JK, Tower D, Woodbury DM, Walter R (eds) Experimental models of epilepsy- a manual for the laboratory worker. Raven Press, New York, pp 347\u2013372"},{"key":"BF02259102_CR8","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1126\/science.7079744","volume":"216","author":"MJ Croucher","year":"1982","unstructured":"Croucher MJ, Collins JF, Meldrum BS (1982) Anticonvulsant action of excitatory amino acid antagonists. Science 216: 899\u2013901","journal-title":"Science"},{"key":"BF02259102_CR9","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/0014-2999(82)90273-4","volume":"83","author":"SJ Czuczwar","year":"1982","unstructured":"Czuczwar SJ, Meldrum BS (1982) Protection against chemically induced seizures by 2-amino-7-phosphonoheptanoic acid. Eur J Pharmacol 83: 335\u2013338","journal-title":"Eur J Pharmacol"},{"key":"BF02259102_CR10","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0014-2999(84)90692-7","volume":"106","author":"G Sarro De","year":"1985","unstructured":"De Sarro G, Meldrum BS, Reavill C (1985) Anticonvulsant action of 2-amino-7-phosphonoheptanoic acid in the substantia nigra. Eur J Pharmacol 106: 175\u2013179","journal-title":"Eur J Pharmacol"},{"key":"BF02259102_CR11","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/j.1528-1157.1988.tb03736.x","volume":"29","author":"FL Engstrom","year":"1988","unstructured":"Engstrom FL, Woodbury DM (1988) Seizure susceptibility in DBA and C57 mice: the effects of various convulsants. Epilepsia 29: 389\u2013395","journal-title":"Epilepsia"},{"key":"BF02259102_CR12","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1016\/0306-4522(82)90212-3","volume":"7","author":"ED French","year":"1982","unstructured":"French ED, Aldinio C, Schwarcz R (1982) Intrahippocampal kainic acid, seizures and local neuronal degeneration: relationships assessed in unanesthetized rats. Neuroscience 7: 2525\u20132536","journal-title":"Neuroscience"},{"key":"BF02259102_CR13","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1111\/j.1528-1157.1988.tb05795.x","volume":"29","author":"K Gale","year":"1988","unstructured":"Gale K (1988) Progression and generalization of seizure discharge: anatomical and neurochemical substrates. Epilepsia 29: S15-S34","journal-title":"Epilepsia"},{"key":"BF02259102_CR14","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/0006-8993(88)90265-X","volume":"461","author":"T Klockgether","year":"1988","unstructured":"Klockgether T, Turski L, Schwarz M, Sontag K-H, Lehmann J (1988) Paradoxical convulsant action of a novel non-competitive N-methyl-D-aspartate (NMDA) antagonist, tiletamine. Brain Res 461: 343\u2013348","journal-title":"Brain Res"},{"key":"BF02259102_CR15","first-page":"343","volume":"252","author":"W Koek","year":"1990","unstructured":"Koek W, Colpaert FC (1990) Selective blockade of N-methyl-D-aspartate (NMDA)-induced convulsions by NMDA antagonists and putative glycine antagonists: relationship with phencyclidine-like behavioral effects. J Pharmacol Exp Ther 252: 343\u2013357","journal-title":"J Pharmacol Exp Ther"},{"key":"BF02259102_CR16","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/0006-8993(90)90243-5","volume":"526","author":"AE Kosobud","year":"1990","unstructured":"Kosobud AE, Crabbe JC (1990) Genetic correlations among inbred strain sensitivities to convulsions induced by 9 convulsant drugs. Brain Res 526: 8\u201316","journal-title":"Brain Res"},{"key":"BF02259102_CR17","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0006-8993(88)91107-9","volume":"448","author":"JD Leander","year":"1988","unstructured":"Leander JD, Lawson RR, Orstein PL, Zimmerman DM (1988) N-methyl-D-aspartic acid-induced lethality in mice: selective antagonism by phencyclidine-like drugs. Brain Res 448: 115\u2013120","journal-title":"Brain Res"},{"key":"BF02259102_CR18","first-page":"65","volume":"246","author":"J Lehmann","year":"1988","unstructured":"Lehmann J, Hutchison AJ, McPherson SE, Mondadori C, Schmutz M, Sinton CM, Tsai C, Murphy DE, Steel DJ, Williams M, Cheney DL, Wood PL (1988) CGS 19755, a selective and competitive N-methyl-D-aspartate-type excitatory amino acid receptor antagonist. J Pharmacol Exp Ther 246: 65\u201375","journal-title":"J Pharmacol Exp Ther"},{"key":"BF02259102_CR19","first-page":"99","volume":"96","author":"JT Litchfield","year":"1949","unstructured":"Litchfield JT, Wilcoxon F (1949) A simplified method of evaluating dose-effects experiments. J Pharmacol Exp Ther 96: 99\u2013113","journal-title":"J Pharmacol Exp Ther"},{"key":"BF02259102_CR20","first-page":"492","volume":"15","author":"ED London","year":"1979","unstructured":"London ED, Coyle JT (1979) Specific binding of [3H]kainic acid to receptor sites in rat brain. Mol Pharmacol 15: 492\u2013505","journal-title":"Mol Pharmacol"},{"key":"BF02259102_CR21","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0014-2999(88)90830-8","volume":"152","author":"W L\u00f6scher","year":"1988","unstructured":"L\u00f6scher W, Nolting B, H\u00f6nack D (1988) Evaluation of CPP, a selective NMDA antagonist, in various models of epilepsy. Comparison with other NMDA antagonists, and with diazepam and phenobarbital. Eur J Pharmacol 152: 9\u201317","journal-title":"Eur J Pharmacol"},{"key":"BF02259102_CR22","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0014-2999(90)90210-W","volume":"185","author":"C Mathis","year":"1990","unstructured":"Mathis C, De Barry J, Ungerer A (1990) NMDA antagonist properties of \u03b3-L-glutamyl-L-aspartate demonstrated on chemically induced seizures in mice. Eur J Pharmacol 185: 53\u201359","journal-title":"Eur J Pharmacol"},{"key":"BF02259102_CR23","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1042\/cs0680113","volume":"68","author":"BS Meldrum","year":"1985","unstructured":"Meldrum BS (1985) Possible therapeutic applications of antagonists of excitatory amino acid neurotransmitters. Clin Sci 68: 113\u2013122","journal-title":"Clin Sci"},{"key":"BF02259102_CR24","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1111\/j.1476-5381.1989.tb14637.x","volume":"98","author":"J-L Moreau","year":"1989","unstructured":"Moreau J-L, Pieri L, Prud'hon B (1989) Convulsions induced by centrally administered NMDA in mice: effects of NMDA antagonists, benzodiazepines, minor tranquilizers and anticonvulsants. Br J Pharmacol 98: 1050\u20131054","journal-title":"Br J Pharmacol"},{"key":"BF02259102_CR25","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1016\/0024-3205(81)90659-7","volume":"29","author":"JV Nadler","year":"1981","unstructured":"Nadler JV (1981) Minireview: Kainic acid as a tool for the study of temporal lobe epilepsy. Life Sci 29: 2031\u20132042","journal-title":"Life Sci"},{"key":"BF02259102_CR26","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/0006-8993(74)90640-4","volume":"77","author":"JW Olney","year":"1974","unstructured":"Olney JW, Rhee V, Ho OL (1974) Kainic acid a powerful neurotoxic analogue of glutamate. Brain Res 77: 507\u2013512","journal-title":"Brain Res"},{"key":"BF02259102_CR27","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/BF01243347","volume":"67","author":"SS Schwarz","year":"1986","unstructured":"Schwarz SS, Freed WJ (1986) Inhibition of quisqualate-induced seizures by glutamic acid diethyl ester and antiepileptic drugs. J Neural Trans 67: 191\u2013203","journal-title":"J Neural Trans"},{"key":"BF02259102_CR28","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1212\/WNL.38.6.920","volume":"38","author":"A Sherwin","year":"1988","unstructured":"Sherwin A, Robitaille Y, Quesney F, Olivier A, Villemure J, Leblanc R, Feindel W, Andermann E, Gotman J, Andermann F, Ethier R, Kish S (1988) Excitatory amino acids are elevated in human epileptic cerebral cortex. Neurology 38: 920\u2013923","journal-title":"Neurology"},{"key":"BF02259102_CR29","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0006-8993(83)91351-3","volume":"265","author":"JT Slevin","year":"1983","unstructured":"Slevin JT, Collins JF, Coyle JT (1983) Analogue interactions with the brain receptor labelled [3H]kainic acid. Brain Res 265: 169\u2013172","journal-title":"Brain Res"},{"key":"BF02259102_CR30","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0028-3908(87)90038-4","volume":"26","author":"H Shinozaki","year":"1987","unstructured":"Shinozaki H, Hirate K, Ishida M (1987) Modification of drug-induced tremor by systemic administration of kainic acid and quisqualic acid in mice. Neuropharmacology 26: 9\u201317","journal-title":"Neuropharmacology"},{"key":"BF02259102_CR31","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/0006-8993(85)90429-9","volume":"336","author":"L Turski","year":"1985","unstructured":"Turski L, Meldrum BS, Collins JF (1985) Anticonvulsant action of\u03b2-kainic acid in mice. Is\u03b2-kainic acid an N-methyl-D-aspartate antagonist? Brain Res 336: 162\u2013166","journal-title":"Brain Res"},{"key":"BF02259102_CR32","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0304-3940(87)90008-5","volume":"73","author":"L Turski","year":"1987","unstructured":"Turski L, Klockgether T, Sontag K-H, Herrling PL, Watkins JC (1987) Muscle relaxant and anticonvulsant activity of 3-((\u00b1)-2-carboxypiperazin-4-yl)-propyl-1-phosphonic acid, a novel N-methyl-D-aspartate antagonist, in rodents. Neurosci Lett 73: 143\u2013148","journal-title":"Neurosci Lett"},{"key":"BF02259102_CR33","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1016\/0024-3205(81)90493-8","volume":"29","author":"P Worms","year":"1981","unstructured":"Worms P, Willigens MT, Lloyd KG (1981) The behavioral effects of systemically administrated kainic acid: a pharmacological analysis. Life Sci 29: 2215\u20132225","journal-title":"Life Sci"}],"container-title":["Experimental Brain Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02259102.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02259102\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02259102","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,16]],"date-time":"2019-05-16T15:01:56Z","timestamp":1558018916000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02259102"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1992,2]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1992,2]]}},"alternative-id":["BF02259102"],"URL":"https:\/\/doi.org\/10.1007\/bf02259102","relation":{},"ISSN":["0014-4819","1432-1106"],"issn-type":[{"value":"0014-4819","type":"print"},{"value":"1432-1106","type":"electronic"}],"subject":[],"published":{"date-parts":[[1992,2]]}}}